A certain subset of monoclonal antibodies - those that bind bivalently - are much more effective against the latest strains of Omicron.
Subscribe to:
Post Comments (Atom)
< + > ViVE and HIMSS Recap – Healthcare IT Today Podcast Episode 190
For the 190th episode of the Healthcare IT Today Podcast , I am joined by a very special guest host, Reese Maynard, MS, MBA, Owner of AskShe...
No comments:
Post a Comment